Pemetrexed is a chemotherapy drug that is manufactured and marketed by Eli Lilly and Company under the brand name Alimta. It is indicated for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery. Its use in non-small ce...
Pemetrexed is indicated for the treatment of the following conditions:
Non-squamous non-small cell lung cancer (NSCLC)
Malignant pleural mesothelioma
The First Hospital of Jilin University, Changchun, Jilin, China
Local Institution - 0021, Birmingham, Alabama, United States
University California San Diego Moores Cancer Center, La Jolla, California, United States
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, United States
Tianjin Cancer Hospital ( Site 0329), Tianjin, Tianjin, China
Hangzhou Cancer Hospital-Medical Oncology ( Site 0302), Hangzhou, Zhejiang, China
The Second Affiliated hospital of Zhejiang University school of medicine ( Site 0301), Hangzhou, Zhejiang, China
Universitätsklinik Köln, Lung Cancer Group Cologne - Innere Medizin I, Köln, Germany
LMU-München Pneumologie und Thorakale Onkologie Medizinische Klinik V; Innenstadt, München, Germany
Universitätsklinikum Hamburg-Eppendorf Hubertus Wald Tumorzentrum - UCCH II. Medizinische Klinik und Poliklinik, Hamburg, Germany
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Research Site, Ho Chi Minh, Vietnam
Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
Saitama Cancer Center, Ina, Saitama, Japan
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
Aix-en-Provence - CH, Aix-en-Provence, France
Amiens - Clinique de l'Europe, Amiens, France
Angers - CHU, Angers, France
Seoul National University Hospital, Seoul, Korea, Republic of
Memorial Sloan Kettering Cancer Center, New York, New York, United States
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, United States
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.